posted January 17, 2022 07:25 am by AviseAnalytics
(4)
$IMNM Immunome, Inc. (NASDAQ: IMNM), a biopharmaceutical company, announced the receipt of a clinical hold letter from the U.S. Food and Drug Administration (FDA) for its recently submitted
...read more